Condition: Tendinopathy · Sponsor: TRB Chemedica AG
PMCF study to further substantiate the effectiveness and safety of OSTENIL® TENDON in the overall as well as indication-specific treatment of pain and restricted mobility in four different tendon disorders (patella tendon, peroneal tendon, medial epicondylus humeri and iliotibial band) in a real-life clinical setting when used according to the instructions for use.
This description comes directly from the study's public registry record.
Raphaela Geiger · +49 89-461483-27 · geiger@trbchemedica.de
Veronika Mussack, Dr. · +49 89-461483-43 · mussack@trbchemedica.de
Always discuss trial participation with your own doctor first.
| Orthopädische Gemeinschaftspraxis ÜBAG | Berlin, State of Berlin, Germany | Recruiting |
| ATOS MVZ meviva Berlin | Berlin, Germany | Completed |
| Orthopädie am Kiesteich | Berlin, Germany | Recruiting |
| Orthopädie Dr. Bentzin | Berlin, Germany | Active Not Recruiting |
| Orthopädische Praxis Dr. Fischer | Potsdam, Germany | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06681051